Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha-Ketoglutarate: A Novel Therapeutic Strategy to Improve Neurogliovascular Coupling and Cognitive Aging in Older Adults

NCT07861867 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT07861867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07861867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha-Ketoglutarate: A Novel Therapeutic Strategy to Improve Neurogliovascular Coupling and Cognitive Aging in Older Adults
Lead sponsor
University of Oklahoma
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
August 31, 2029
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain aging, cerebrovascular function